Bharat Biotech has signed a technology transfer agreement with Spain’s Biofabri to enable end-to-end manufacturing of MTBVAC, with a Phase 3 study in India expected to start recruitment in Q1 2026
Source :- Companies Read More
Bharat Biotech inks tech transfer pact with Biofabri for MTBVAC TB vaccine
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
